As I pointed out several times before, sales numbers will be low at this stage and can't be expected per quarter. Have a look how this business operates and who their clients are, see anns 24/04/25, then you will understand. It is not a company selling millions of items for $2, they sell 1 or 2 devices for $ million(s) and they just have started. 12 of the top 20 pharma are still to order, some have already started testing and evaluating. More sales will come in once those 12 big guys made their decision which at this stage, is very highly likely to be positive.
CF positive for 2nd consecutive quarter, any cap raising will be done for outlaying costs due to orders and not to desperately trying to keep the light on, perfect scenario to jump on board while still cheap and flying under the ASX radar.
GLTA
CC5 Price at posting:
1.6¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)